Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan.

Sanders-Buell E, Rutvisuttinunt W, Todd CS, Nasir A, Bradfield A, Lei E, Poltavee K, Savadsuk H, Kim JH, Scott PT, de Souza M, Tovanabutra S.

J Med Virol. 2013 Jul;85(7):1170-9. doi: 10.1002/jmv.23575.

PMID:
23918535
[PubMed - indexed for MEDLINE]
2.

Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time.

Samimi-Rad K, Nasiri Toosi M, Masoudi-Nejad A, Najafi A, Rahimnia R, Asgari F, Shabestari AN, Hassanpour G, Alavian SM, Asgari F.

Arch Virol. 2012 Oct;157(10):1959-65. Epub 2012 Jun 13.

PMID:
22695769
[PubMed - indexed for MEDLINE]
3.

Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.

Tanimoto T, Nguyen HC, Ishizaki A, Chung PT, Hoang TT, Nguyen VT, Kageyama S, Oka S, Pham VT, Ichimura H.

J Med Virol. 2010 Aug;82(8):1355-63. doi: 10.1002/jmv.21787.

PMID:
20572071
[PubMed - indexed for MEDLINE]
4.

Complex patterns of HCV epidemic in Suzhou: evidence for dual infection and HCV recombination in East China.

Du H, Qi Y, Hao F, Huang Y, Mao L, Ji S, Huang M, Qin C, Yan R, Zhu X, Zhang C.

J Clin Virol. 2012 Jul;54(3):207-12. doi: 10.1016/j.jcv.2012.04.017. Epub 2012 May 16.

PMID:
22595306
[PubMed - indexed for MEDLINE]
5.

Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.

Calado RA, Rocha MR, Parreira R, Piedade J, Venenno T, Esteves A.

J Med Virol. 2011 Apr;83(4):608-15. doi: 10.1002/jmv.21955.

PMID:
21328374
[PubMed - indexed for MEDLINE]
6.

Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.

Zhao R, Peng J, Tang L, Huang H, Liu M, Kong W, Pang B.

J Med Virol. 2013 Oct;85(10):1712-23. doi: 10.1002/jmv.23650. Epub 2013 Jul 19.

PMID:
23868809
[PubMed - indexed for MEDLINE]
7.

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.

Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, Ncube F, Parry JV.

J Viral Hepat. 2011 Apr;18(4):262-70. doi: 10.1111/j.1365-2893.2010.01297.x.

PMID:
20456636
[PubMed - indexed for MEDLINE]
8.

Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies.

van den Berg CH, van de Laar TJ, Kok A, Zuure FR, Coutinho RA, Prins M.

J Viral Hepat. 2009 Aug;16(8):568-77. doi: 10.1111/j.1365-2893.2009.01105.x. Epub 2009 Feb 23.

PMID:
19243497
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.

Beld M, Penning M, van Putten M, van den Hoek A, Lukashov V, McMorrow M, Goudsmit J.

J Clin Microbiol. 1998 Oct;36(10):3002-6.

PMID:
9738057
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Hepatitis C virus molecular epidemiology in Uzbekistan.

Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, Yunusova Z, Mizokami M.

J Med Virol. 2003 Mar;69(3):367-75.

PMID:
12526047
[PubMed - indexed for MEDLINE]
11.

Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region.

Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L.

J Med Virol. 2004 Oct;74(2):246-52.

PMID:
15332273
[PubMed - indexed for MEDLINE]
12.

Active hepatitis C infection and HCV genotypes prevalent among the IDUs of Khyber Pakhtunkhwa.

ur Rehman L, Ullah I, Ali I, Khan IA, Iqbal A, Khan S, Khan SH, Zaman KU, ullah Khan N, Swati ZA, Jahangiri AT.

Virol J. 2011 Jun 28;8:327. doi: 10.1186/1743-422X-8-327.

PMID:
21711541
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.

Micalessi MI, Gérard C, Ameye L, Plasschaert S, Brochier B, Vranckx R.

J Med Virol. 2008 Apr;80(4):640-5. doi: 10.1002/jmv.21145.

PMID:
18297717
[PubMed - indexed for MEDLINE]
14.

Hepatitis C virus recombinants are rare even among intravenous drug users.

Viazov S, Ross SS, Kyuregyan KK, Timm J, Neumann-Haefelin C, Isaeva OV, Popova OE, Dmitriev PN, El Sharkawi F, Thimme R, Michailov MI, Roggendorf M.

J Med Virol. 2010 Feb;82(2):232-8. doi: 10.1002/jmv.21631.

PMID:
20029799
[PubMed - indexed for MEDLINE]
15.

Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.

Aitken CK, Tracy SL, Revill P, Bharadwaj M, Bowden DS, Winter RJ, Hellard ME.

J Clin Virol. 2008 Apr;41(4):293-6. doi: 10.1016/j.jcv.2007.12.007. Epub 2008 Feb 1.

PMID:
18242125
[PubMed - indexed for MEDLINE]
16.

[Current situation and trends in the hepatitis C virus genotype distribution among injecting drug users in the Czech Republic].

Krekulová L, Rehák V, Strunecký O, Nēmecek V.

Epidemiol Mikrobiol Imunol. 2009 Apr;58(2):84-9. Czech.

PMID:
19526922
[PubMed - indexed for MEDLINE]
17.

Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.

Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG; Cyprus IVDU Network, Kostrikis LG.

J Med Virol. 2010 Feb;82(2):263-70. doi: 10.1002/jmv.21690. Erratum in: J Med Virol. 2010 May;82(5):910-1.

PMID:
20029809
[PubMed - indexed for MEDLINE]
18.

Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.

Matheï C, Wollants E, Verbeeck J, Van Ranst M, Robaeys G, Van Damme P, Buntinx F.

Eur J Clin Microbiol Infect Dis. 2005 Aug;24(8):514-22.

PMID:
16133411
[PubMed - indexed for MEDLINE]
19.

Tracking the entry routes of hepatitis C virus as a surrogate of HIV in an HIV-low prevalence country, the Philippines.

Kageyama S, Agdamag DM, Alesna ET, Abellanosa-Tac-An IP, Corpuz AC, Telan EF, Que ER, Leaño PS, Jereza LD, Emphasis YE, Prasetyo AA, Tanimoto T, Ichimura H.

J Med Virol. 2009 Jul;81(7):1157-62. doi: 10.1002/jmv.21516.

PMID:
19475613
[PubMed - indexed for MEDLINE]
20.

Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil.

Lopes CL, Teles SA, Espírito-Santo MP, Lampe E, Rodrigues FP, Motta-Castro AR, Marinho TA, Reis NR, Silva AM, Martins RM.

Rev Saude Publica. 2009 Aug;43 Suppl 1:43-50.

PMID:
19669064
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk